Cerebellar patients have intact feedback control that can be leveraged to improve reaching

  1. Amanda M Zimmet
  2. Di Cao
  3. Amy J Bastian
  4. Noah J Cowan  Is a corresponding author
  1. Johns Hopkins University, United States
  2. Kennedy Krieger Institute, United States

Abstract

It is thought that the brain does not simply react to sensory feedback, but rather uses an internal model of the body to predict the consequences of motor commands before sensory feedback arrives. Time-delayed sensory feedback can then be used to correct for the unexpected—perturbations, motor noise, or a moving target. The cerebellum has been implicated in this predictive control process. Here we show that the feedback gain in patients with cerebellar ataxia matches that of healthy subjects, but that patients exhibit substantially more phase lag. This difference is captured by a computational model incorporating a Smith predictor in healthy subjects that is missing in patients, supporting the predictive role of the cerebellum in feedback control. Lastly, we improve cerebellar patients’ movement control by altering (phase advancing) the visual feedback they receive from their own self movement in a simplified virtual reality setup.

Data availability

All data generated or analyzed during this study will be openly on the JHU Data Archive under DOI 10.7281/T1/BCARLC.The data will be available here: https://archive.data.jhu.edu/dataverse/LIMBS

The following data sets were generated

Article and author information

Author details

  1. Amanda M Zimmet

    Biomedical Engineering, Johns Hopkins University, Baltimore, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-1457-3072
  2. Di Cao

    Mechanical Engineering, Johns Hopkins University, Baltimore, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-1547-9929
  3. Amy J Bastian

    Kennedy Krieger Institute, Baltimore, United States
    Competing interests
    No competing interests declared.
  4. Noah J Cowan

    Mechanical Engineering, Johns Hopkins University, Baltimore, United States
    For correspondence
    ncowan@jhu.edu
    Competing interests
    Noah J Cowan, Reviewing editor, eLife.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-2502-3770

Funding

National Institutes of Health (HD040289)

  • Amy J Bastian
  • Noah J Cowan

Applied Physics Laboratory Graduate Fellowship

  • Amanda M Zimmet

National Science Foundation (1825489)

  • Di Cao
  • Amy J Bastian
  • Noah J Cowan

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Richard B Ivry, University of California, Berkeley, United States

Ethics

Human subjects: The experimental protocol was approved by the Institutional Review Board at Johns Hopkins University School of Medicine (protocol # IRB00182673) and all participants gave informed consent prior to joining this study, according to the Declaration of Helsinki.

Version history

  1. Received: November 1, 2019
  2. Accepted: October 6, 2020
  3. Accepted Manuscript published: October 7, 2020 (version 1)
  4. Version of Record published: October 21, 2020 (version 2)

Copyright

© 2020, Zimmet et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,192
    Page views
  • 323
    Downloads
  • 20
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, PubMed Central, Scopus.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Amanda M Zimmet
  2. Di Cao
  3. Amy J Bastian
  4. Noah J Cowan
(2020)
Cerebellar patients have intact feedback control that can be leveraged to improve reaching
eLife 9:e53246.
https://doi.org/10.7554/eLife.53246

Share this article

https://doi.org/10.7554/eLife.53246

Further reading

    1. Neuroscience
    Kiwamu Kudo, Kamalini G Ranasinghe ... Srikantan S Nagarajan
    Research Article

    Alzheimer’s disease (AD) is characterized by the accumulation of amyloid-β and misfolded tau proteins causing synaptic dysfunction, and progressive neurodegeneration and cognitive decline. Altered neural oscillations have been consistently demonstrated in AD. However, the trajectories of abnormal neural oscillations in AD progression and their relationship to neurodegeneration and cognitive decline are unknown. Here, we deployed robust event-based sequencing models (EBMs) to investigate the trajectories of long-range and local neural synchrony across AD stages, estimated from resting-state magnetoencephalography. The increases in neural synchrony in the delta-theta band and the decreases in the alpha and beta bands showed progressive changes throughout the stages of the EBM. Decreases in alpha and beta band synchrony preceded both neurodegeneration and cognitive decline, indicating that frequency-specific neuronal synchrony abnormalities are early manifestations of AD pathophysiology. The long-range synchrony effects were greater than the local synchrony, indicating a greater sensitivity of connectivity metrics involving multiple regions of the brain. These results demonstrate the evolution of functional neuronal deficits along the sequence of AD progression.

    1. Medicine
    2. Neuroscience
    Luisa Fassi, Shachar Hochman ... Roi Cohen Kadosh
    Research Article

    In recent years, there has been debate about the effectiveness of treatments from different fields, such as neurostimulation, neurofeedback, brain training, and pharmacotherapy. This debate has been fuelled by contradictory and nuanced experimental findings. Notably, the effectiveness of a given treatment is commonly evaluated by comparing the effect of the active treatment versus the placebo on human health and/or behaviour. However, this approach neglects the individual’s subjective experience of the type of treatment she or he received in establishing treatment efficacy. Here, we show that individual differences in subjective treatment - the thought of receiving the active or placebo condition during an experiment - can explain variability in outcomes better than the actual treatment. We analysed four independent datasets (N = 387 participants), including clinical patients and healthy adults from different age groups who were exposed to different neurostimulation treatments (transcranial magnetic stimulation: Studies 1 and 2; transcranial direct current stimulation: Studies 3 and 4). Our findings show that the inclusion of subjective treatment can provide a better model fit either alone or in interaction with objective treatment (defined as the condition to which participants are assigned in the experiment). These results demonstrate the significant contribution of subjective experience in explaining the variability of clinical, cognitive, and behavioural outcomes. We advocate for existing and future studies in clinical and non-clinical research to start accounting for participants’ subjective beliefs and their interplay with objective treatment when assessing the efficacy of treatments. This approach will be crucial in providing a more accurate estimation of the treatment effect and its source, allowing the development of effective and reproducible interventions.